Back to Search
Start Over
Antigenics cancer vaccine promising in kidney cancer.
- Source :
- PharmaWatch: Biotechnology; Jul2007, Vol. 6 Issue 7, p6-6, 1/2p
- Publication Year :
- 2007
-
Abstract
- The article reports on the revelation of U.S.-based Antigenics Inc. in its end-of-study results of therapeutic cancer vaccine Oncophage. According to biotechnology firm, its end-of-study results have shown that Oncophage prolongs recurrence-free survival of about 45% in patients with intermediate-risk kidney cancer.
Details
- Language :
- English
- Volume :
- 6
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- PharmaWatch: Biotechnology
- Publication Type :
- Report
- Accession number :
- 25688129